BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2019
View Archived Issues
Cantargia announces start of CAN-10 development project for systemic sclerosis and myocarditis
Read More
Once-a-month oral contraceptive
Read More
Phase II data presented for KVD-001 in patients with diabetic macular edema
Read More
InMed receives CTA approval for phase I study of INM-755
Read More
First patient dosed in phase I study of BJ-001 in advanced or metastatic solid tumors
Read More
Discovery of novel inhaled JAK inhibitor for the treatment of respiratory diseases
Read More
DR-10601 shows promise for the treatment of type 2 diabetes and obesity in preclinical models
Read More
First preclinical data in DLBCL for BCMA-targeting 2 + 1 T-cell engager CC-93269
Read More
Innovent begins phase I study in China with anti-LAG-3 antibody IBI-110
Read More
CD3/CD7-IT causes clinical remission and rapid immune reconstitution in SR-aGvHD: phase I/II results
Read More
Quantitative and inducible modulation of the circadian clock with light using photocaged longdayisin
Read More
First-in-human data for novel oral multikinase inhibitor SKLB-1028 in R/R AML
Read More
With reduced toxicity, can HSCT make it to Hall of Fame?
Read More
AMR Centre patents new antibacterials
Read More
Vedanta initiates first-in-patient study of VE-800 with Opdivo in advanced or metastatic cancer
Read More
Guangzhou Henovcom Bioscience discloses ENPP2 inhibitors
Read More
Indivior selects CRO to conduct phase I study of INDV-2000
Read More
Nerviano Medical Sciences presents new IDH1 and/or IDH2 mutant inhibitors
Read More
Gilead Sciences identifies new benzamides for liver diseases
Read More
LAIMU synthesizes new compounds for allergy
Read More
FDA removes clinical hold on Abeona's phase III VIITAL study of EB-101
Read More
Sinovent studies small-molecule human URAT1 inhibitor XNW-3009 in phase I
Read More
Orca opens phase Ib study of TregGraft in hematologic malignancies
Read More
